Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 5 | 2020 | 64 | 2.110 |
Why?
|
| Brain Ischemia | 5 | 2022 | 261 | 1.120 |
Why?
|
| Vasospasm, Intracranial | 2 | 2020 | 18 | 1.080 |
Why?
|
| Stroke | 7 | 2025 | 1049 | 1.020 |
Why?
|
| Cerebral Hemorrhage | 2 | 2020 | 153 | 0.960 |
Why?
|
| Neurophysiological Monitoring | 3 | 2020 | 37 | 0.840 |
Why?
|
| Intensive Care Units | 5 | 2022 | 517 | 0.790 |
Why?
|
| Hematoma, Subdural | 1 | 2020 | 28 | 0.630 |
Why?
|
| Vasoconstriction | 1 | 2020 | 95 | 0.620 |
Why?
|
| Hyponatremia | 1 | 2020 | 74 | 0.600 |
Why?
|
| Hospital Mortality | 2 | 2024 | 1075 | 0.590 |
Why?
|
| Sodium | 1 | 2020 | 281 | 0.580 |
Why?
|
| Albumins | 2 | 2017 | 92 | 0.560 |
Why?
|
| Disease Management | 2 | 2020 | 563 | 0.560 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 67 | 0.540 |
Why?
|
| Brain Edema | 1 | 2018 | 65 | 0.540 |
Why?
|
| Neuroprotective Agents | 3 | 2015 | 161 | 0.520 |
Why?
|
| Critical Care | 6 | 2022 | 680 | 0.470 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 314 | 0.470 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 60 | 0.420 |
Why?
|
| Moyamoya Disease | 1 | 2014 | 42 | 0.420 |
Why?
|
| Magnesium Sulfate | 1 | 2012 | 51 | 0.360 |
Why?
|
| Coma | 2 | 2022 | 55 | 0.360 |
Why?
|
| Brain Death | 1 | 2011 | 74 | 0.330 |
Why?
|
| Renal Dialysis | 1 | 2018 | 951 | 0.330 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 942 | 0.310 |
Why?
|
| Central Nervous System Diseases | 2 | 2020 | 99 | 0.280 |
Why?
|
| Intracranial Pressure | 3 | 2019 | 215 | 0.270 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2015 | 113 | 0.220 |
Why?
|
| Middle Aged | 12 | 2025 | 28839 | 0.220 |
Why?
|
| Pseudotumor Cerebri | 2 | 2016 | 64 | 0.210 |
Why?
|
| Oceania | 2 | 2020 | 4 | 0.200 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 322 | 0.200 |
Why?
|
| Middle East | 2 | 2020 | 37 | 0.200 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 215 | 0.200 |
Why?
|
| Glasgow Coma Scale | 2 | 2022 | 203 | 0.200 |
Why?
|
| Adult | 11 | 2024 | 31666 | 0.190 |
Why?
|
| Latin America | 2 | 2020 | 101 | 0.190 |
Why?
|
| Asia | 2 | 2020 | 125 | 0.190 |
Why?
|
| Intracranial Aneurysm | 2 | 2013 | 82 | 0.190 |
Why?
|
| Neurology | 3 | 2020 | 121 | 0.190 |
Why?
|
| North America | 2 | 2020 | 256 | 0.190 |
Why?
|
| Humans | 28 | 2025 | 131504 | 0.190 |
Why?
|
| Aged | 8 | 2025 | 21238 | 0.190 |
Why?
|
| Internationality | 2 | 2020 | 130 | 0.190 |
Why?
|
| Neurosurgery | 2 | 2020 | 73 | 0.180 |
Why?
|
| Status Epilepticus | 1 | 2024 | 157 | 0.180 |
Why?
|
| Europe | 2 | 2020 | 372 | 0.180 |
Why?
|
| Consciousness | 1 | 2022 | 46 | 0.180 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2021 | 19 | 0.170 |
Why?
|
| Risk Factors | 3 | 2020 | 10952 | 0.170 |
Why?
|
| Aftercare | 1 | 2022 | 154 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2025 | 594 | 0.160 |
Why?
|
| Male | 13 | 2025 | 65158 | 0.160 |
Why?
|
| Patient Comfort | 1 | 2020 | 5 | 0.160 |
Why?
|
| Hospitals, Private | 1 | 2020 | 23 | 0.160 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 17 | 0.160 |
Why?
|
| Female | 14 | 2025 | 71087 | 0.160 |
Why?
|
| Hemodynamic Monitoring | 1 | 2020 | 16 | 0.160 |
Why?
|
| Resuscitation Orders | 1 | 2020 | 32 | 0.160 |
Why?
|
| Resource Allocation | 1 | 2020 | 52 | 0.160 |
Why?
|
| Hospitals, Public | 1 | 2020 | 49 | 0.160 |
Why?
|
| Head-Down Tilt | 2 | 2017 | 26 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 775 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2020 | 110 | 0.150 |
Why?
|
| Texas | 2 | 2020 | 3614 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 506 | 0.140 |
Why?
|
| Health Resources | 1 | 2020 | 128 | 0.140 |
Why?
|
| Patient Admission | 1 | 2020 | 184 | 0.140 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 39 | 0.140 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 148 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 115 | 0.140 |
Why?
|
| Atrial Fibrillation | 1 | 2025 | 732 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 207 | 0.130 |
Why?
|
| Rest | 1 | 2017 | 63 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2020 | 1235 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2116 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1404 | 0.120 |
Why?
|
| Hospitalization | 3 | 2024 | 1939 | 0.120 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2017 | 218 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2020 | 566 | 0.120 |
Why?
|
| Palliative Care | 1 | 2020 | 444 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 272 | 0.120 |
Why?
|
| Optic Disk | 1 | 2016 | 46 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2020 | 379 | 0.110 |
Why?
|
| Logistic Models | 1 | 2020 | 1831 | 0.110 |
Why?
|
| Health Personnel | 1 | 2020 | 549 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1160 | 0.110 |
Why?
|
| Time Factors | 2 | 2025 | 6273 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2015 | 135 | 0.110 |
Why?
|
| Myocardial Stunning | 1 | 2014 | 19 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 3090 | 0.100 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 106 | 0.100 |
Why?
|
| Length of Stay | 1 | 2020 | 1393 | 0.100 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 99 | 0.100 |
Why?
|
| Therapeutic Occlusion | 1 | 2013 | 3 | 0.100 |
Why?
|
| Olfaction Disorders | 1 | 2014 | 28 | 0.100 |
Why?
|
| Serum Albumin | 1 | 2014 | 110 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2020 | 556 | 0.100 |
Why?
|
| Headache | 1 | 2014 | 110 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2019 | 711 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2020 | 17648 | 0.100 |
Why?
|
| Brain | 2 | 2017 | 3237 | 0.090 |
Why?
|
| Incidence | 1 | 2020 | 3344 | 0.090 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 572 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 403 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1217 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2011 | 197 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1624 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 463 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 223 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 1297 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2015 | 1450 | 0.080 |
Why?
|
| Prognosis | 1 | 2020 | 4951 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 3403 | 0.080 |
Why?
|
| Young Adult | 4 | 2024 | 10092 | 0.080 |
Why?
|
| Cause of Death | 1 | 2011 | 510 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 543 | 0.070 |
Why?
|
| Informed Consent | 1 | 2011 | 343 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2011 | 392 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2011 | 253 | 0.070 |
Why?
|
| Stents | 1 | 2013 | 778 | 0.070 |
Why?
|
| Electroencephalography | 2 | 2024 | 869 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 2020 | 228 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3911 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12936 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 682 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2985 | 0.050 |
Why?
|
| Adolescent | 3 | 2024 | 20917 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2025 | 220 | 0.050 |
Why?
|
| Morbidity | 1 | 2024 | 258 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 6916 | 0.050 |
Why?
|
| Consciousness Disorders | 1 | 2022 | 26 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 100 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 134 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 4037 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2024 | 215 | 0.040 |
Why?
|
| United States | 3 | 2024 | 11794 | 0.040 |
Why?
|
| Herpesvirus 2, Human | 1 | 2021 | 14 | 0.040 |
Why?
|
| Acyclovir | 1 | 2021 | 47 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2021 | 100 | 0.040 |
Why?
|
| Personnel Management | 1 | 2020 | 6 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2020 | 20 | 0.040 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3834 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 2020 | 53 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 103 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 506 | 0.030 |
Why?
|
| Hospital Bed Capacity | 1 | 2017 | 28 | 0.030 |
Why?
|
| Bed Rest | 1 | 2017 | 24 | 0.030 |
Why?
|
| Prevalence | 1 | 2024 | 2692 | 0.030 |
Why?
|
| Weightlessness Simulation | 1 | 2017 | 23 | 0.030 |
Why?
|
| Cerebral Veins | 1 | 2017 | 22 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1478 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2022 | 706 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 322 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 331 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2015 | 51 | 0.030 |
Why?
|
| Weightlessness | 1 | 2017 | 85 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 794 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 133 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2016 | 6485 | 0.030 |
Why?
|
| Serum Albumin, Human | 1 | 2014 | 8 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 229 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 32 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 615 | 0.030 |
Why?
|
| Space Flight | 1 | 2017 | 171 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 519 | 0.020 |
Why?
|
| Physicians | 1 | 2020 | 634 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 282 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1634 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1305 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1910 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 1590 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1213 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8589 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5120 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3452 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 766 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 34341 | 0.010 |
Why?
|
VENKATASUBBA RAO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_